chr8-91334332-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000276609.8(SLC26A7):c.680G>A(p.Arg227Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000868 in 1,612,756 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000276609.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A7 | NM_052832.4 | c.680G>A | p.Arg227Gln | missense_variant | 6/19 | ENST00000276609.8 | NP_439897.1 | |
SLC26A7 | NM_134266.2 | c.680G>A | p.Arg227Gln | missense_variant | 6/19 | NP_599028.1 | ||
SLC26A7 | NM_001282356.2 | c.680G>A | p.Arg227Gln | missense_variant | 7/20 | NP_001269285.1 | ||
SLC26A7 | NM_001282357.2 | c.-141G>A | 5_prime_UTR_variant | 7/19 | NP_001269286.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A7 | ENST00000276609.8 | c.680G>A | p.Arg227Gln | missense_variant | 6/19 | 1 | NM_052832.4 | ENSP00000276609 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000140 AC: 35AN: 250490Hom.: 1 AF XY: 0.000140 AC XY: 19AN XY: 135396
GnomAD4 exome AF: 0.0000712 AC: 104AN: 1460500Hom.: 1 Cov.: 30 AF XY: 0.0000826 AC XY: 60AN XY: 726542
GnomAD4 genome AF: 0.000236 AC: 36AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74440
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 17, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at